These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31927626)

  • 1. Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.
    Dorfman L; Amir J; Attias J; Bilavsky E
    Eur J Pediatr; 2020 May; 179(5):807-812. PubMed ID: 31927626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
    Amir J; Wolf DG; Levy I
    Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing outcome of infants with congenital cytomegalovirus and hearing impairment.
    Bilavsky E; Shahar-Nissan K; Pardo J; Attias J; Amir J
    Arch Dis Child; 2016 May; 101(5):433-8. PubMed ID: 26826174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
    Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P;
    J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing outcomes in children with congenital cytomegalovirus infection: From management controversies to lack of parents' knowledge.
    Aldè M; Caputo E; Di Berardino F; Ambrosetti U; Barozzi S; Piatti G; Zanetti D; Pignataro L; Cantarella G
    Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111420. PubMed ID: 36563581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss.
    Pasternak Y; Ziv L; Attias J; Amir J; Bilavsky E
    J Pediatr; 2018 Aug; 199():166-170. PubMed ID: 29605391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.
    del Rosal T; Baquero-Artigao F; Blázquez D; Noguera-Julian A; Moreno-Pérez D; Reyes A; Vilas J
    J Clin Virol; 2012 Sep; 55(1):72-4. PubMed ID: 22750017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital Cytomegalovirus-Associated Sensorineural Hearing Loss in Children: Identification Following Universal Newborn Hearing Screening, Effect of Antiviral Treatment, and Long-Term Hearing Outcomes.
    Rohren L; Shanley R; Smith M; Yue M; Huang TC; Nelson P; Hernandez-Alvarado N; Schleiss MR; Gravel KE
    Ear Hear; 2024 Jan-Feb 01; 45(1):198-206. PubMed ID: 37563758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
    Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
    J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of congenital cytomegalovirus infection in children early identified by extended hearing-targeted screening.
    Forli F; Capobianco S; Berrettini S; Bruschini L; Lorenzoni F; Fiori S; Lazzerini F
    Int J Pediatr Otorhinolaryngol; 2024 Sep; 184():112070. PubMed ID: 39191004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled Trial.
    Chung PK; Schornagel FAJ; Soede W; van Zwet EW; Kroes ACM; Oudesluys-Murphy AM; Vossen ACTM
    J Pediatr; 2024 May; 268():113945. PubMed ID: 38336204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Audiologic Outcomes in Twins with Congenital Cytomegalovirus Infection.
    Botti C; Palma S; Roversi MF; Monzani D; Berardi A; Genovese E
    J Int Adv Otol; 2020 Apr; 16(1):130-133. PubMed ID: 32209524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin fetal therapy and neonatal therapy with antiviral drugs improve neurological outcome of infants with symptomatic congenital cytomegalovirus infection.
    Tanimura K; Shi Y; Uchida A; Uenaka M; Imafuku H; Ikuta T; Fujioka K; Morioka I; Deguchi M; Minematsu T; Yamada H
    J Reprod Immunol; 2021 Feb; 143():103263. PubMed ID: 33422744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort study of the universal neonatal urine screening for congenital cytomegalovirus infection.
    Yamada H; Tanimura K; Fukushima S; Fujioka K; Deguchi M; Sasagawa Y; Tairaku S; Funakoshi T; Morioka I
    J Infect Chemother; 2020 Aug; 26(8):790-794. PubMed ID: 32273174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valganciclovir for symptomatic congenital cytomegalovirus disease.
    Kimberlin DW; Jester PM; Sánchez PJ; Ahmed A; Arav-Boger R; Michaels MG; Ashouri N; Englund JA; Estrada B; Jacobs RF; Romero JR; Sood SK; Whitworth MS; Abzug MJ; Caserta MT; Fowler S; Lujan-Zilbermann J; Storch GA; DeBiasi RL; Han JY; Palmer A; Weiner LB; Bocchini JA; Dennehy PH; Finn A; Griffiths PD; Luck S; Gutierrez K; Halasa N; Homans J; Shane AL; Sharland M; Simonsen K; Vanchiere JA; Woods CR; Sabo DL; Aban I; Kuo H; James SH; Prichard MN; Griffin J; Giles D; Acosta EP; Whitley RJ;
    N Engl J Med; 2015 Mar; 372(10):933-43. PubMed ID: 25738669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.
    Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE
    Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
    Yilmaz Çiftdogan D; Vardar F
    J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing outcomes in children with Congenital Cytomegalovirus: A multi-center, single-enterprise experience.
    Tapasak B; Cronkite DA; Hustedt-Mai AR; Morlet TM; Parkes WJ; Maul TM; Pritchett CV
    Int J Pediatr Otorhinolaryngol; 2022 Dec; 163():111376. PubMed ID: 36370539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir.
    McCrary H; Sheng X; Greene T; Park A
    Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():124-127. PubMed ID: 30611098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing in Children with Congenital Cytomegalovirus Infection: Results of a Longitudinal Study.
    Goderis J; Keymeulen A; Smets K; Van Hoecke H; De Leenheer E; Boudewyns A; Desloovere C; Kuhweide R; Muylle M; Royackers L; Schatteman I; Dhooge I
    J Pediatr; 2016 May; 172():110-115.e2. PubMed ID: 26858192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.